Advertisement
Advertisement
PACB
Pacific Biosciences of California, Inc.
2.25
USDSponsored
-0.18
-7.20%
Nov 06, 15:57 UTC -5
Closed
After-Market
2.28
+0.02
+1.06%
Pacific Biosciences of California, Inc. (PACB) Earnings
PACB Earnings Reports
Positive Surprise Ratio
PACB beat 22 of 43 last estimates.
51%
Next Report
Date of Next Report
Feb 09, 2027
Estimate for Q4 26 (Revenue/ EPS)
$45.12M
/-$0.13
Implied change from Q3 26 (Revenue/ EPS)
+11.23%
/+18.18%
Implied change from Q4 25 (Revenue/ EPS)
+1.05%
/+8.33%
Pacific Biosciences of California, Inc. earnings per share and revenue
On Nov 04, 2026, PACB reported earnings of -0.11 USD per share (EPS) for Q3 26, beating the estimate of -0.15 USD, resulting in a 26.96% surprise. Revenue reached 40.56 million, compared to an expected 41.19 million, with a -1.54% difference. The market reacted with a -4.71% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.13 USD, with revenue projected to reach 45.12 million USD, implying an increase of 18.18% EPS, and increase of 11.23% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
GLOBUS MEDICAL INC
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.22
Actual
$1.23
Surprise
+0.75%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
CVRx, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.52
Surprise
-2.91%
FAQ
What were Pacific Biosciences of California, Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Pacific Biosciences of California, Inc. reported EPS of -$0.11, beating estimates by 26.96%, and revenue of $40.56M, -1.54% below expectations.
How did the market react to Pacific Biosciences of California, Inc.'s Q3 2026 earnings?
The stock price moved down -4.71%, changed from $2.55 before the earnings release to $2.43 the day after.
When is Pacific Biosciences of California, Inc. expected to report next?
The next earning report is scheduled for Feb 09, 2027.
What are the forecasts for Pacific Biosciences of California, Inc.'s next earnings report?
Based on --
analysts, Pacific Biosciences of California, Inc. is expected to report EPS of -$0.13 and revenue of $45.12M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.